Arocaine-A DC 4%+0.001% (Injection)
1.8 ml cartridge: ৳ 48.33 (5's pack: ৳ 241.65)
Medicine Details
| Category | Details |
|---|---|
| Generic | Articaine hydrochloride epinephrine |
| Company | Jayson pharmaceuticals ltd |
Title
- Articaine and Epinephrine Local Anesthetic
Categories
- Dental Anesthesia
- Local Anesthetic
- Dental Procedure Aid
Description
- Indications: Local, infiltrative, or conductive anesthesia in both simple and complex dental procedures.
- Pharmacology: Local anesthetics block nerve impulses, while epinephrine prolongs tissue concentration.
- Dosage & Administration: Recommended volumes and concentrations for various types of anesthetic procedures.
- Interactions: Potential interactions with monoamine oxidase inhibitors, beta-adrenergic antagonists, tricyclic antidepressants, phenothiazines, and butyrophenones.
- Contraindications: Contraindicated in patients hypersensitive to sulfites.
- Side Effects: Common and rare side effects including gastrointestinal, musculoskeletal, general, nervous system, cardiovascular, and respiratory effects.
- Pregnancy & Lactation: Pregnancy Category C; caution advised during lactation.
- Use in Special Populations: Safety and dosage considerations for pediatric patients, and patients with renal or hepatic insufficiency.
- Therapeutic Class: Local & Surface Anesthesia
Attributes
- Color Options:
- Clear
- Function:
- Infiltrative Anesthesia
- Conductive Anesthesia
- Nerve Block Anesthesia
- Oral Surgery Anesthesia
- Active Ingredients:
- Articaine
- Epinephrine
- Recommended Dosage:
- 0.5 mL to 5.1 mL for different procedures
- Maximum Dose:
- 7 mg/kg of body weight
- Onset of Action:
- Related to nerve fiber diameter, myelination, and conduction velocity
- Absorption:
- Slowed by epinephrine for prolonged tissue concentration
- Administration Method:
- Submucosal Infiltration
- Nerve Block
- Interaction Warnings:
- Avoid concurrent use with specific medications
- Careful patient monitoring advised
- Hypersensitivity Warning:
- Contraindicated in sulfite hypersensitive patients
- Pregnancy Warning:
- Category C; risk-benefit assessment for use during pregnancy
- Lactation Warning:
- Caution advised due to unknown excretion in human milk
- Pediatric Use:
- Safety for doses greater than 7 mg/kg not established
- Special Populations:
- Dosage considerations for pediatric, renal, and hepatic impaired patients
- Therapeutic Class:
- Local Anesthetic